STAR · NSE
Not in active coverage. Cited reporting has mentioned Strides Pharma Science, the record of those mentions is below. Your interest is logged; coverage expands by demand.
Strides Pharma Science stated that the US Food and Drug Administration issued three observations after inspecting its Alathur facility.
Promoter Arun Kumar Pillai bought an additional 10 lakh shares, equivalent to a 1.08% stake, in Strides Pharma Science for Rs 99 crore at Rs 990 per share. ... SBI Life Insurance Company was the seller in the Strides Pharma block deal. The insurer held a 4.76% stake in the company as of June 2026.
Strides Pharma Science Limited Board Meeting for considering audited financial results for the quarter and financial year ended March 31, 2026 commenced at 12:30 hrs IST and concluded at 14:15 hrs IST.
The USFDA issued an Establishment Inspection Report (EIR) for Strides Pharma Science's Bengaluru facility following a cGMP inspection conducted from May 12 to May 20, 2026, which concluded with five observations.
This page lists where cited reporting has mentioned Strides Pharma Science. It is not the full dossier: developments here are single mentions, not corroborated records. We compile and cite; we do not opine.
New here? The reader's guide explains every page, plate by plate.
fregime is informational research software. Content on this page is factual reporting compiled from cited public sources; nothing here is advice, and nothing here expresses an opinion on any security. fregime is not registered with SEBI as an investment adviser or research analyst. Before making investment decisions, consult a SEBI-registered adviser. Price figures are delayed end-of-day values cited to the exchange's published file, never live quotes.